China Resources Pharmaceutical (03320.HK) Subsidiary Completes Issuance of RMB800 Million Medium-Term Notes

Zhitong Finance APP News, China Resources Pharmaceutical (03320.HK) announced that its wholly-owned subsidiary China Resources Pharmaceutical Holdings Limited (China Resources Pharmaceutical Holdings) has completed the issuance of the third tranche of 2026 medium-term notes (the Third Tranche of 2026 Medium-Term Notes) in China. The Third Tranche of 2026 Medium-Term Notes with a principal amount of RMB800 million has been issued, with a term of three years and a coupon rate of 1.45% per annum.